Advertisement

Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report

      Radiation-associated angiosarcoma (RAAS) develops in the setting of lymphedema or previous radiation; patients typically present with cutaneous lesions rather than parenchymal lesions.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hodgson N.C.
        • Bowen-Wells C.
        • Moffat F.
        • et al.
        Angiosarcomas of the breast: a review of 70 cases.
        Am J Clin Oncol. 2007; 30: 570-573
        • Scow J.
        • Reynolds C.
        • Degnim A.
        • et al.
        Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience.
        J Surg Oncol. 2010; 101: 401-407
        • Jiang W.
        • Murphy J.
        • van de Rijn M.
        • et al.
        Secondary breast angiosarcoma and germ line BRCA mutations: discussion of genetic susceptibility.
        J Radiat Oncol. 2013; 2: 331-335
        • Tavtigian S.V.
        • Byrnes G.B.
        • Goldgar D.E.
        • et al.
        Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.
        Hum Mutat. 2008; 29: 1342-1354
        • Palta M.
        • Morris C.G.
        • Grobmyer S.R.
        • et al.
        Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy.
        Cancer. 2010; 116: 1872-1878
        • Strobbe L.J.
        • Peterse H.L.
        • van Tinteren H.
        • et al.
        Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforseen sequela.
        Breast Cancer Res Treat. 1998; 47: 101-109
        • Vorburger S.A.
        • Xing Y.
        • Hunt K.K.
        • et al.
        Angiosarcoma of the breast.
        Cancer. 2005; 104: 2682-2688
        • Hui A.
        • Henderson M.
        • Speakman D.
        • et al.
        Angiosarcoma of the breast: a difficult surgical challenge.
        Breast. 2012; 21: 584-589
        • Benson J.
        • Osborne M.
        Letter to the editor.
        Breast Cancer Res Treat. 1999; 55: 293
        • Huang J.
        • Mackillop W.J.
        Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma.
        Cancer. 2001; 92: 172-180
        • Gao X.
        • Fisher S.G.
        • Emami B.
        Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
        Int J Radiat Oncol Biol Phys. 2003; 56: 1038-1045
        • Venkitaraman A.R.
        Cancer susceptibility and the functions of BRCA1 and BRCA2.
        Cell. 2002; 108: 171-182
        • Narod S.
        • Foulkes W.
        BRCA1 and BRCA2: 1994 and beyond.
        Nat Rev Cancer. 2004; 4: 665-676
        • West J.G.
        • Weitzel J.N.
        • Tao M.L.
        • et al.
        BRCA mutations and the risk of angiosarcoma after breast cancer treatment.
        Clin Breast Cancer. 2008; 8: 533-537
        • Kadouri L.
        • Sagi M.
        • Goldberg Y.
        • et al.
        Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations.
        Breast Cancer Res Treat. 2013; 140: 207-211